Page 3 - Drugmaker
Sanofi India net profit at Rs 530 crore in September quarter
The company's revenue from operations rose to Rs 754.5 crore as compared to Rs 686.6 crore in the year-ago period
 "Sanofi India net profit at Rs 530 crore in September quarter")
SoftBank said to build a $5 billion stake in Swiss drugmaker Roche
The Japanese conglomerate is now one of Roche's largest investors, according to data compiled by Bloomberg.
 "SoftBank said to build a $5 billion stake in Swiss drugmaker Roche")
Pharma majors join hands for Molnupiravir trial for Covid-19 treatment
Leading drug makers have decided to collaborate for clinical trial of the investigational oral antiviral drug Molnupiravir
 "Pharma majors join hands for Molnupiravir trial for Covid-19 treatment")
Five drugmakers to jointly start local trial of Merck & Co's Covid-19 drug
(Reuters) -Five Indian generic drugmakers, including Cipla and Dr Reddy's Laboratories, said on Tuesday they would jointly conduct a clinical trial in India for Merck & Co's experimental anti-viral drug to treat mild COVID-19 in non-hospitalised patients.
 "Five drugmakers to jointly start local trial of Merck & Co's Covid-19 drug")
Drugmaker Glenmark fourth quarter net profit up 6% at Rs 233.87 crore
The rise came on account of higher sales.
 "Drugmaker Glenmark fourth quarter net profit up 6% at Rs 233.87 crore")
GlaxoSmithKline Pharmaceuticals reports net profit of Rs 157 cr in Q3
GlaxoSmithKline Pharmaceuticals on Friday said it has registered a consolidated net profit of Rs 156.51 crore for the third quarter ended December
 "GlaxoSmithKline Pharmaceuticals reports net profit of Rs 157 cr in Q3")
US drugmaker Merck's Kenneth Frazier to step down as CEO in June-end
Frazier, 66, will remain with the drugmaker as executive chairman for a transition period to be determined by the board.
 "US drugmaker Merck's Kenneth Frazier to step down as CEO in June-end")
Drugmakers to hike prices for 2021 as Covid pressure puts revenues at risk
Drugmakers including Pfizer Inc, Sanofi SA, and GlaxoSmithKline Plc plan to raise US prices on more than 300 drugs in the United States on Jan 1
 "Drugmakers to hike prices for 2021 as Covid pressure puts revenues at risk")
AstraZeneca, Qure.ai to bring AI solutions to detect lung cancer
The partnership aims to harness and scale-up the use of this technology to improve early-stage detection of lung cancer in the markets involved, to reduce mortality rates and improve patient outcomes.
 "AstraZeneca, Qure.ai to bring AI solutions to detect lung cancer")
Drugmaker Merck divests stake in vaccine-maker Moderna after stock surge
(Reuters) - U.S. drugmaker Merck & Co said on Wednesday it has sold its equity investment in Moderna Inc, after benefiting from a surge in the stock price of the vaccine developer this year.
 "Drugmaker Merck divests stake in vaccine-maker Moderna after stock surge")
PLI scheme: Govt looks to get Rs 50,000 crore investments in pharma
The incentive will be in the range of 5-10 per cent of production value, sources said.
 "PLI scheme: Govt looks to get Rs 50,000 crore investments in pharma")
Novartis lifts 2020 forecast as drugmakers see hospitals coping with Covid
ZURICH (Reuters) - Novartis joined rivals Merck, Johnson & Johnson and Roche in predicting the worst of the pandemic may be over for drugmakers, amid signs healthcare systems have learned how to cope with surging infections without shutting down all services.
 "Novartis lifts 2020 forecast as drugmakers see hospitals coping with Covid")
Covid-19 vaccine makers must deliver to US in time to get full payments
The Cambridge, Massachusetts, biotech's $1.5-billion deal pays out in full if its vaccine receives regulatory clearance by January 31, 2021
 "Covid-19 vaccine makers must deliver to US in time to get full payments")
Moderna shares soar over 16% over coronavirus vaccine trial result
All the 45 patients in the trial produced neutralising antibodies which are believed to be important for building immunity
 "Moderna shares soar over 16% over coronavirus vaccine trial result")
Drugmakers slash prices to be eligible for China's bulk-buy program
Sale prices of over 100 types of commonly used drugs are on average about 17 to 18 times of their manufacturing costs, the statement said
 "Drugmakers slash prices to be eligible for China's bulk-buy program")
Drugmakers from Pfizer to GSK to hike US prices up to 10% on over 200 drugs
More price increases are expected to be announced later this week, which could affect the median and range.
 "Drugmakers from Pfizer to GSK to hike US prices up to 10% on over 200 drugs")
MNCs, domestic drug makers did equally well in terms of growth rate
The data shows that in the last 12 months, multinational drugmakers have also done equally well in the Indian market in terms of growth rate
 "MNCs, domestic drug makers did equally well in terms of growth rate")
Medicines costing less than Rs 5 per dose may be taken out of price control
If this goes through, drugmakers will have the liberty to raise the prices of these drugs by up to 10 per cent every year
 "Medicines costing less than Rs 5 per dose may be taken out of price control")
Dr Reddy's Labs looks to recover from Q1 blues with multiple growth drivers
Steady improvement in the US and India market growth keeps analysts positive
Drug companies step up global investments to tap biosimilars
Cipla is investing Rs 600 crore to set up a manufacturing plant for biosimilars in South Africa
 "Drug companies step up global investments to tap biosimilars")
